Microarray testing can detect more fetal abnormalities

12/5/2012 | Bloomberg

Chromosomal microarrays spotted more fetal abnormalities than current prenatal tests called karyotypes, according to two studies published in the New England Journal of Medicine. One study showed that microarray testing was just as effective as karyotyping in detecting genetic changes linked to birth defects. In the second study, microarrays helped identify the cause of stillbirth in 87% of the cases, compared with 71% with conventional testing.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX